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ABSTRACT
Background. Patients who require acute initiation of dialysis have higher mortality rates when compared with patients with
planned starts. Our primary objective was to explore the reasons and risk factors for acute initiation of renal replacement
therapy (RRT) among patients with end-stage kidney disease (ESKD). Our secondary objective was to determine the
difference in glomerular filtration rate (GFR) change in the year preceding RRT between elective and acute dialysis starts.
Methods. We conducted a single-centre retrospective observational study. ESKD patients either started dialysis electively
(planned starters) or acutely and were known to renal services for >90 (unplanned starters) or <90 days (urgent starters).
Results. In all, 825 consecutive patients initiated dialysis between January 2013 and December 2015. Of these, 410 (49.7%)
patients had a planned start. A total of 415 (50.3%) patients had an acute start on dialysis: 244 (58.8%) unplanned and 171
(41.2%) urgent. The reasons for acute dialysis initiation included acute illness (58%) and unexplained decline to ESKD (33%).
Cardiovascular disease [n¼30 (22%)] and sepsis [n¼65 (48%)] accounted for the majority of acute systemic illness. Age and
premorbid cardiovascular disease were independent risk factors for acute systemic illness among unplanned starts,
whereas autoimmune disease accounted for the majority of urgent starts. The rate of decline in GFR was greater in the
month preceding RRT among acute dialysis starters compared with planned starters (P<0.001).
Conclusions. Cardiovascular disease and advancing age were independent risk factors for emergency dialysis initiation
among patients known to renal services for >3 months. The rapid and often unpredictable loss of renal function in the
context of acute systemic illness poses a challenge to averting emergency dialysis start.
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INTRODUCTION
Delayed referral to nephrology services and urgent initiation of
dialysis are independent risk factors for morbidity and mortality
among patients with end-stage kidney disease (ESKD) [1–7].
Urgent dialysis initiation among patients not known to renal
services is associated with worse outcomes, including hospitali-
zation, increased health care costs [8] and poorer quality of life
[9]. Despite this, late nephrology referrals requiring unplanned
dialysis initiation account for 20% of patients initiating dialysis
[1, 3, 10].
Several studies have identified risk factors associated with
delayed referral. These include patient-related factors such as
older age [11, 12], comorbid illness [13, 14] and lower socio-eco-
nomic status [15, 16]. Additional factors relate to the health sys-
tem, such as the absence of communication between referring
physicians and nephrologists and a lack of consensus among
physicians regarding the appropriate timing of referral [17].
Even among patients known to renal services, inpatient
‘suboptimal’ dialysis starts occur in >40% of patients [18, 19].
The estimated glomerular filtration rate (eGFR) remains an im-
portant determinant for when to refer for dialysis, however,
there is clearly a need for more frequent surveillance in pre-
ESKD care to enable earlier recognition of those cases with rap-
idly progressive renal disease. A better understanding of the
reasons for urgent dialysis initiation and being able to identify
those patients at risk of a rapid decline in GFR may facilitate
timely intervention and improve patient outcome.
Our primary objective was to explore the reasons for and
risk factors associated with acute renal replacement therapy
(RRT) initiation. Our secondary objective was to determine the
difference in the rate of decline in eGFR in the year preceding di-
alysis initiation between elective and acute RRT starts.
MATERIALS ANDMETHODS
Setting
This study was conducted at the West London Renal and
Transplant Centre, a regional kidney and transplant medicine
centre. It serves a population of 1.6 million people, looking af-
ter >3500 patients on RRT.
Study population
We conducted a retrospective analysis of patients initiating
chronic dialysis. All patients diagnosed with ESKD initiating di-
alysis between January 2013 and December 2015 were included
in the analysis. Patients were followed from dialysis initiation
until the last clinical encounter prior to 31 July 2017. Chronic
RRT was defined by the need for dialysis for a minimum of
3 months in patients with Stage 5 chronic kidney disease (CKD).
Patients transplanted pre-emptively were excluded from the
analysis.
Data collection
A prospective database of patients presenting to renal services
and initiating RRT is routinely maintained. Following the identi-
fication of cases, electronic patient records and laboratory
records were reviewed and data collected retrospectively.
We categorized patients into planned, unplanned and urgent
starters. Planned starters were those starting RRT electively (as
an outpatient, with an arteriovenous fistula or planned central
venous dialysis catheter/peritoneal dialysis catheter in place).
Unplanned starters were patients known to renal services for
>90 days who required acute initiation of RRT. Urgent starters
were those patients known to renal services <90 days who re-
quired acute RRT. Although timing of referral to renal services
prior to ESKD is a continuous variable, we selected 90 days as a
‘cut-off’ for late referrals, which allows our results to be inter-
preted in the context of other studies [2, 6, 7, 11].
We collected demographic data (age, gender, ethnicity, time
known to renal services), clinical data (primary renal disease,
comorbid illness, initial dialysis modality) and reasons why
patients required acute initiation of dialysis. The eGFR was cal-
culated using the Modification of Diet in Renal Disease (MDRD)
formula from serum creatinine values at the time of dialysis ini-
tiation and at 1, 3, 6 and 12 months prior to dialysis initiation.
Creatinine measurements were made in clinical laboratories us-
ing the Jaffe method. Measurements made between different
laboratories were not standardized. However, the results are
deemed accurate for routine clinical use. In accordance with
reporting guidelines, descriptive tables were not subjected to
statistical testing [20].
Statistics
Multinomial logistic regression was used to assess risk
factors associated with acute dialysis start. Planned starts on di-
alysis were used as the reference group. Candidate factors in-
cluded ethnicity (reference group: Caucasian), gender (reference
group: female), age range (reference group: age 75 years), pri-
mary renal diagnosis (reference group: diabetic nephropathy)
and co-morbid illness. Data are presented as unadjusted and
adjusted odds ratio (OR) with confidence interval (CI) and P-
value.
We assessed the change in calculated eGFR over time in the
year preceding dialysis initiation. We selected the time points
of 1, 3, 6 and 12 months prior to dialysis initiation. If data were
outside these time intervals by >15% (e.g. >5 days for the 1-
month value or 55 days for the 1-year value), then we consid-
ered the data unavailable. Where patients had creatinine meas-
urements more often, we selected the creatinine value closest
to the predefined time point (1, 3, 6 or 12 months). Repeated
measures analysis of variance with Greenhouse–Geisser correc-
tion was used to assess the interaction of planned status and
eGFR change in the preceding 12 months prior to dialysis. Post
hoc tests using the Bonferroni correction were used to assess
differences in eGFR rate of change compared with planned
starters. Data are presented as mean difference [standard
error (95% CI); P-value]. Graphs were constructed and statisti-
cal analysis performed using Prism 5.0 (GraphPad Software,
La Jolla, CA, USA) and SPSS version 22.0 (IBM, Armonk, NY,
USA).
Ethics
The UK Renal Association has suggested that data on the ‘per-
centage of patients commencing RRT referred <3 months and
<12 months before date of starting RRT’ are collected and ana-
lysed as part of clinical governance. As such, this study was
deemed a quality improvement project and research ethics ap-
proval was not sought. Furthermore, this was a retrospective
study and all treatment decisions were made prior to our
assessment.
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RESULTS
Demographics
A total of 904 consecutive patients initiated RRT between
January 2013 and December 2015 in our centre. In all, 79 patients
(8.7%) were excluded from the analysis, as they had a planned
start with a pre-emptive renal transplant. A total of 825 patients
initiated on dialysis were included in the analysis (Table 1). Of
these, 410 (49.7%) patients had a planned start. The remaining
415 (50.3%) patients had an acute start on dialysis, of which, 244
(58.8%) had an unplanned start and 171 (41.2%) had an urgent
start (Table 1). Unplanned starters were known to renal services
for significantly less time than planned starters (3.86 4.2 years
versus 5.064.8 years; P< 0.001).
The mean age at RRT initiation was 61.3 (615.8) years. The
majority of our RRT cohort were of Asian ethnicity [n¼ 338
(40.6%)], followed by Caucasian [n¼ 293 (35.2%)], Black [n¼ 163
(19.6%)] and other ethnicities [n¼ 38 (4.6%)]. The leading cause
of ESKD was diabetic nephropathy (41.5%), followed by autoim-
mune glomerulonephritis (GN; 16.1%), autosomal dominant
polycystic kidney disease (ADPKD; 6.6%) and renovascular dis-
ease (2.9%). The aetiology of ESKD was unknown in 18.6% of
patients.
Reasons for acute dialysis initiation
Reasons for acute initiation of dialysis were divided into pa-
tient-related factors, acute systemic illness or unexpected accel-
erated decline to ESKD (Table 2 and Figure 1). Health care
behaviour–related factors consisted of non-attendance to clinic,
previous refusal of RRT initiation despite advanced kidney dis-
ease, intentional consumption of drugs known to be nephro-
toxic (e.g. herbal medications) and immigration (overseas
patients presenting to UK health care with ESKD). Acute sys-
temic illness consisted of cardiovascular events, sepsis, vascu-
lar disease, autoimmunity, major surgery, obstructive uropathy,
Table 1. Baseline characteristics of patients with planned, unplanned or urgent starts to RRT categorized by the cause for emergency
presentation
Planned
Unplanned Urgent
Total
Systemic
illness
Accelerated
decline
Patient
related
Systemic
illness
Accelerated
decline
Patient
related
Patients, n 410 135 81 28 106 57 8 825
Age (years), mean (SD) 61.9 (14.9) 68.0 (11.4) 63.3 (17.1) 55.8 (16.8) 63.9 (16.0) 51.1 (18.3) 68.9 (15.6) 61.3 (15.8)
Time known to renal (years), mean (SD) 5.0 (4.8) 4.2 (4.2) 3.0 (4.1) 4.2 (4.5) 0.0 (0.0) 0.0 (0.0) 0.0 (0.0) 3.6 (4.5)
Sex, n (%)
Male 256 (62.4) 91 (67.4) 49 (60.5) 16 (57.1) 69 (65.1) 40 (70.2) 2 (25.0) 526 (63.2)
Female 44 (32.6) 32 (39.5) 12 (42.9) 37 (34.9) 17 (29.8) 6 (75.0)
Ethnicity, n (%)
Asian 188 (45.9) 53 (38.5) 33 (40.7) 11 (39.3) 32 (30.2) 16 (28.1) 4 (50.0) 338 (40.6)
Black 77 (18.8) 24 (17.8) 18 (22.2) 7 (25.0) 15 (14.2) 19 (33.3) 1 (12.5) 163 (19.6)
Other 21 (5.1) 6 (4.4) 5 (6.2) 2 (7.1) 2 (1.9) 1 (1.8) 0 (0.0) 38 (4.6)
Caucasian 124 (30.2) 53 (39.9) 25 (30.9) 8 (28.6) 57 (53.8) 21 (36.8) 3 (37.5) 293 (35.2)
Primary renal diagnosis, n (%)
Other 62 (15.1) 22 (16.3) 8 (9.9) 2 (7.1) 35 (33.0) 12 (21.1) 3 (37.5) 145 (17.4)
Unknown 82 (20.0) 19 (14.1) 14 (17.3) 6 (21.4) 8 (7.5) 22 (38.6) 3 (37.5) 155 (18.6)
Renovascular 9 (2.2) 7 (5.2) 4 (4.9) 0 (0.0) 2 (1.9) 2 (3.5) 0 (0.0) 24 (2.9)
Glomerulonephritis 60 (14.6) 15 (11.1) 13 (16.0) 4 (14.3) 38 (35.8) 2 (3.5) 0 (0.0) 134 (16.1)
ADPKD 27 (6.6) 3 (2.2) 1 (1.2) 2 (7.1) 0 (0.0) 0 (0.0) 0 (0.0) 27 (6.6)
DM 127 (50.4) 69 (51.1) 41 (50.6) 14 (50.0) 23 (21.7) 19 (33.3) 2 (25.0) 170 (41.5)
Age range (years), n (%)
<45 57 (13.9) 5 (3.7) 15 (18.5) 7 (25.0) 16 (15.1) 24 (42.1) 1 (12.5) 127 (15.3)
45–59 114 (27.8) 23 (17.0) 13 (16.0) 10 (35.7) 23 (21.7) 12 (21.1) 0 (0.0) 197 (23.7)
60–74 146 (25.6) 65 (48.1) 29 (35.8) 7 (25.0) 28 (26.4) 13 (22.8) 4 (50.0) 294 (35.3)
>75 93 (22.7) 42 (31.1) 24 (29.6) 4 (14.3) 39 (36.8) 8 (14.0) 3 (37.5) 214 (25.7)
DM, n (%) 186 (45.4) 91 (67.4) 38 (59.3) 15 (53.6) 33 (31.1) 22 (38.6) 3 (37.5) 402 (48.3)
Cardiac disease, n (%) 86 (21.0) 61 (45.2) 23 (28.4) 5 (17.9) 31 (29.2) 14 (24.6) 2 (25.0) 224 (26.9)
Cerebrovascular disease, n (%) 30 (7.3) 22 (16.3) 6 (7.4) 1 (3.6) 9 (8.5) 4 (7.0) 1 (12.5) 73 (8.8)
Peripheral vascular disease, n (%) 34 (8.3) 21 (15.6) 13 (16.0) 2 (7.1) 10 (9.4) 5 (8.8) 1 (12.5) 86 (10.3)
Viral disease, n (%) 11 (2.7) 6 (4.4) 5 (6.2) 2 (7.1) 7 (6.6) 6 (10.5) 1 (12.5) 38 (4.6)
Hypertension, n (%) 103 (25.1) 54 (40.0) 35 (43.2) 11 (39.3) 48 (45.3) 28 (49.1) 6 (75.0) 291 (35.0)
Haematological malignancy, n (%) 10 (2.4) 7 (5.2) 3 (3.7) 1 (3.6) 8 (7.5) 3 (5.3) 1 (12.5) 33 (4.0)
Biochemistry, n (%)
Creatinine (lmol/L) 672 (211) 678 (240) 767 (309) 1001 (372) 878 (482) 1013 (589) 790 (328) 744 (335)
Modality, n (%)
Peritoneal dialysis 66 (16.1) 1 (0.70) 2 (2.5) 0 (0.0) 0 (0.0) 0 (0.0) 0 (0.0) 69 (8.3)
Haemodialysis 344 (83.9) 134 (99.3) 79 (97.5) 28 (100.0) 106 (100.0) 57 (100.0) 8 (100.0) 763 (91.7)
Data were complete for age, gender, planned status, mortality, initial RRT modality, primary renal diagnosis and reason for emergency RRT start. The following varia-
bles had missing data: ethnicity (n¼1), initial RRT access (n¼7), time known to renal services prior to RRT start (n¼13), creatinine (n¼1).
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drug toxicity and other systemic diseases (e.g. haematological
malignancy). Patients who presented with ‘unexpected acceler-
ated decline in renal function’ had no discrete systemic illness
but presented with either volume overload, symptoms of urae-
mia or hyperkalaemia/significantly elevated serum creatinine
on routine blood testing.
Cardiovascular disease (22%) and sepsis (48%) accounted for
the majority of acute systemic illness presentations among
unplanned starters. In contrast, autoimmune disease (36%) and
sepsis (26%) accounted for most of the acute illness presenta-
tions among urgent starters (Table 2).
Risk factors for acute RRT initiation
Unplanned dialysis initiation from acute systemic illness.
Patients <45 years of age [OR 0.28 (95% CI 0.10–0.78); P¼ 0.02]
and 45–59 years of age [OR 0.47 (95% CI 0.25–0.88); P¼ 0.02] were
significantly less likely to present needing unplanned dialysis
initiation from acute systemic illness compared with patients
>75 years of age. Cardiovascular comorbidities and risk factors
were independently associated with unplanned dialysis initia-
tion from acute systemic illness. These included renovascular
disease [OR 4.94 (95% CI 1.12–21.89); P¼ 0.04], diabetes mellitus
[DM; OR 5.46 (95% CI 2.46–11.76); P< 0.001], cardiac disease [OR
1.96 (95% CI 1.24–3.11); P< 0.001], previous cerebrovascular acci-
dent (CVA; OR 1.94 (95% CI 1.03–3.66); P¼ 0.04] and hypertension
(HTN; OR 1.69 (95% CI 1.09–2.60); P¼ 0.02]. Other risk factors in-
cluded ‘other’ renal diagnoses [OR 2.85 (95% CI 1.24–6.54);
P¼ 0.01] (Table 3).
Unplanned dialysis initiation from accelerated unexpected
decline in renal function. Patients 45–59 years of age [OR 0.39
(95% CI 0.18–0.85); P ¼ 0.02] were at lower risk of accelerated de-
cline in renal function compared with patients >75 years of age,
Table 2. Reasons for initiation of RRT in patients with unplanned and urgent presentations to nephrology services
Unplanned Urgent
Systemic
illness
Unexpected
decline
Patient
related
Systemic
illness
Unexpected
decline
Patient
related
Patient related ,n (%)
Non-compliance/non-attendance – – 11 (39) – – 0 (0)
Previous refusal of haemodialysis/conservative care – – 13 (46) – – 1 (13)
Drug toxicity (illicit/intentional) – – 3 (11) – – 3 (38)
Immigration, n (%) – – 1 (4) – – 4 (50)
Systemic illness, n (%)
Sepsis 65 (48) – – 28 (26) – –
Cardiovascular 30 (22) – – 11 (10) – –
Peripheral vascular disease 4 (3) – – 1 (1) – –
Autoimmunity 6 (4) – – 38 (36) – –
Major surgery 14 (10) – – 5 (5) – –
Obstructive uropathy 3 (2) – – 5 (5) – –
Other systemic causes with secondary renal involvement 10 (7) – – 14 (13) – –
Iatrogenic drug toxicity 3 (2) – – 4 (4) – –
Accelerated decline, n (%)
Accelerated decline (unplanned) – 81 (100) – – – –
Accelerated decline (urgent) – – – – 57 –
Total, n (%) 135 81 28 106 57 8
FIGURE 1: Proportion of patients requiring planned, unplanned and urgent initiation of dialysis.
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whereas patients <45 years of age were of similar risk. Risk fac-
tors for presenting with dialysis initiation from accelerated de-
cline in renal function among unplanned starters included the
presence of DM [OR 3.83 (95% CI 1.34–10.99); P ¼ 0.01] and HTN
[HR 2.19 (95% CI 1.32–3.65); P < 0.001] (Table 3).
Urgent dialysis initiation from acute systemic illness. Factors
associated with urgent dialysis start from acute systemic illness
included autoimmune GN [OR 6.07 (95% CI 2.10–17.56);
P¼ 0.001], HTN [OR 2.53 (95% CI 1.56–4.10); P< 0.001)], ‘other’ di-
agnoses [OR 4.48 (95% CI 1.61–12.43); P< 0.001] and age. Younger
patients were at greatest risk of presenting needing urgent dial-
ysis initiation from acute systemic illness. Patients <45 years of
age [OR 2.13 (95% CI 1.00–4.55); P¼ 0.05], 45–59 years [OR 2.19
(95% CI 1.13–4.24); P¼ 0.02] and 60–74 years [OR 2.56 (95% CI
1.40–4.69); P< 0.001] were more likely to present needing
unplanned dialysis initiation from acute systemic illness com-
pared with patients >75 years old. Compared with Caucasian
patients, Asian patients were less likely to present with urgent
RRT initiation from acute systemic illness [OR 0.55 (95% CI 0.32–
0.95); P¼ 0.03] (Table 3).
Urgent dialysis initiation from accelerated unexpected decline
in renal function. Risk factors for unexpected accelerated de-
cline in renal function leading to ESKD included viral disease
[OR (95% CI 1.47–15.38); P¼ 0.01] and HTN [OR 3.15 (95% CI 1.70–
5.85); P< 0.001]. Patients were more likely to be <45 years of age
compared with patients >75 years [OR (10.11 (95% CI 3.65–28.0);
P< 0.001]. Compared with Caucasian patients, Asian patients
were less likely to present with urgent RRT initiation from accel-
erated decline in renal function [OR 0.45 (95% CI 0.22–0.95);
P¼ 0.04] (Table 3).
Acute dialysis initiation from patient-related factors. It was not
possible to assess independent risk factors for acute RRT initia-
tion associated with patient-related factors because of the rela-
tively small sample size.
Rate of decline in GFR prior to dialysis initiation
Unplanned starters with an acute systemic illness (7.763.4 mL/
min/1.73 m2; P¼ 1.00), unplanned starters with an unexplained
decline to ESKD (7.164.7 mL/min/1.73 m2; P¼ 0.230) and urgent
starters with an acute systemic illness (7.164.7 mL/min/
1.73 m2; P¼ 0.159) had similar eGFRs at the time of dialysis initi-
ation compared with planned starters (7.66 3.0 mL/min/
1.73 m2). In contrast, urgent starters with an unexplained de-
cline to ESKD (6.564.1 mL/min/1.73 m2; P¼ 0.019) had a signifi-
cantly lower eGFR at initiation of dialysis compared with
planned starters.
The change in eGFR at 1, 3, 6 and 12 months prior to initia-
tion of dialysis was ascertained where possible in order to pro-
vide an estimate of the eGFR decline over the 12 months
Table 3. Outcomes from regression analysis identifying risk factors for emergency commencement of RRT, expressed as unadjusted OR and CI
with P-values to delineate significance at the P<0.05 level
Unplanned with
systemic illness
Unplanned with
unexpected decline
Urgent with
systemic illness
Urgent with
unexpected decline
OR (95% CI) Sig. OR (95% CI) Sig. OR (95% CI) Sig. OR (95% CI) Sig.
Sex
Male 1.15 (0.74–1.78) 0.54 0.89 (0.54–1.48) 0.65 1.18 (0.72–1.92) 0.52 1.61 (0.83–3.13) 0.16
Reference: female
Ethnicity
Asian 0.66 (0.41–1.08) 0.10 0.97 (0.53–1.76) 0.92 0.55 (0.32–0.93) 0.03 0.47 (0.22–1.00) 0.05
Black 0.90 (0.49–1.65) 0.73 1.46 (0.72–2.49) 0.30 0.64 (0.32–1.28) 0.21 1.43 (0.66–3.09) 0.36
Other 1.16 0.40–3.37) 0.79 1.83 (0.59–5.63) 0.30 0.31 (0.07–1.42) 0.13 0.27 (0.03–2.31) 0.23
Reference: Caucasian
Primary renal diagnosis
Other 2.85 (1.24–6.54) 0.01 1.19 (0.38–3.78) 0.77 4.48 (1.61–12.43) 0.00 1.71 (0.39–7.56) 0.48
Unknown 2.40 (0.96–5.06) 0.06 2.09 (0.66–6.56) 0.21 0.79 (0.23–2.74) 0.71 4.09 (0.89–18.94) 0.07
Renovascular disease 4.95 (1.12–21.89) 0.04 3.91 (0.69–22.34) 0.13 1.17 (0.16–8.81) 0.88 9.29 (0.79–108.7) 0.08
Glomerulonephritis 5.93 (0.46–77.07) 0.17 1.41 (0.19–10.67) 0.74 6.07 (2.10–17.56) 0.001 0.14 (0.01–2.91) 0.20
ADPKD 0.77 (0.19–3.20) 0.72 0.33 (0.04–3.11) 0.33 NA 0.99 NA 0.99
Reference: diabetic nephropathy
Comorbid illness
DM 5.42 (2.46–11.76) 0.00 3.83 (1.34–10.99) 0.01 1.39 (0.55–3.55) 0.48 2.13 (0.50–9.01) 0.31
Cardiac disease 1.96 (1.24–3.11) 0.00 1.18 (0.65–2.14) 0.59 1.59 (0.91–2.78) 0.10 1.66 (0.76–3.61) 0.20
Cerebrovascular disease 1.94 (1.03–3.66) 0.04 0.85 (0.32–2.23) 0.74 1.12 (0.52–2.83) 0.66 0.98 (0.30–3.17) 0.97
Peripheral vascular disease 1.24 (0.59–2.62) 0.57 1.92 (0.81–4.55) 0.14 1.62 (0.64–4.12) 0.31 0.78 (0.20–3.00) 0.71
Viral disease 1.46 (0.49–4.31) 0.49 3.03 (0.97–9.34) 0.06 2.28 (0.80–6.54) 0.12 6.02 (1.86–19.23) 0.00
Hypertension 1.69 (1.09–2.60) 0.02 2.19 (1.32–3.65) 0.00 2.53 (1.56–4.10) 0.00 3.16 (1.91–6.80) 0.00
Haematological malignancy 1.46 (0.50–4.26) 0.49 1.55 (0.39–6.12) 0.54 1.79 (0.63–5.08) 0.28 1.66 (0.76–3.61) 0.20
Reference: no comorbid illness
Age range (years)
<45 0.28 (0.10–0.78) 0.02 1.20 (0.54–2.65) 0.66 2.13 (1.00–4.55) 0.05 10.11 (3.65–28.0) 0.00
45–59 0.47 (0.25–0.88) 0.02 0.39 (0.18–0.84) 0.02 2.19 (1.13–4.24) 0.02 1.34 (0.47–3.80) 0.59
60–74 0.93 (0.56–1.55) 0.78 0.66 (0.35–1.26) 0.21 2.56 (1.40–4.69) 0.00 1.17 (0.43–3.15) 0.76
Reference: >75 . . .
Sig., significance.
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preceding dialysis. Among patients known to renal services for
>3 months, blood results were available for between 78 and 93%
of patients at each time point. However, among urgent dialysis
starters, blood results were available for between 28 and 59% of
patients at each time point (Supplementary data, Table S1).
Compared with planned starters, unplanned starters with sys-
temic illness (4.560.9, P< 0.001), unplanned starters with ac-
celerated unexpected decline in renal function (3.661.2,
P¼ 0.029), urgent starters with systemic illness (2661.5;
P< 0.001) and urgent starters with unexpected accelerated de-
cline in renal function (1362.4, P< 0.001) had a greater rate of
eGFR decline in the 12 months preceding dialysis (Figure 2;
Supplementary data, Table S1).
DISCUSSION
Acute initiation of dialysis is common, occurring in 46% of our
ESKD cohort. This is consistent with other studies, reporting 40–
63% inpatient initiation of dialysis [1, 3, 10]. Suboptimal dialysis
initiation occurs in up to 56% of patients known to renal serv-
ices for 1 year [18]. Reasons for unplanned initiation of RRT
among patients known to renal services often include acute ill-
ness, unexpected decline in renal function, service-related and
patient health behaviour–related factors [10, 21]. Understanding
the reasons for urgent dialysis initiation, with a focus on risk
Table 4. Outcomes from regression analysis identifying risk factors for emergency commencement of RRT, expressed as adjusted OR and CI
with P-values to delineate significance (sig.) at the P<0.05 level
Unplanned
systemic illnessa
Unplanned
unexpected declinea
Urgent
systemic illnessa
Urgent
unexpected declinea
Adjusted
OR (95% CI) P-value
Adjusted
OR (95% CI) P-value
Adjusted
OR (95% CI) P-value
Adjusted
OR (95% CI) P-value
Age 1.02 (1.01–1.04) <0.001 1.00 (0.99–1.02) 0.67 1.01 (1.00–1.03) 0.12 0.94 (0.92–0.96) <0.01
Comorbid illness
DM 5.40 (2.49–11.72) <0.001 3.50 (1.25–9.87) 0.02 1.32 (0.53–3.28) 0.55 1.85 (0.43–7.86) 0.41
Cardiac 2.11 (1.34–3.31) <0.001 1.24 (0.69–2.22) 0.47 1.80 (1.05–3.11) 0.03 1.87 (0.87–4.01) 0.11
CVA 1.83 (0.97–3.44) 0.06 0.86 (0.34–2.21) 0.76 1.17 (0.51–2.71) 0.71 0.95 (0.30–3.07) 0.94
Vascular 1.33 (0.64–2.75) 0.45 1.83 (0.79–4.24) 0.16 1.49 (0.60–3.68) 0.39 0.77 (0.20–3.06) 0.72
Viral 1.46 (0.50–4.24) 0.49 2.40 (0.79–7.26) 0.12 2.07 (0.75–5.75) 0.16 4.85 (1.55–15.16) 0.01
HTN 1.67 (1.09–2.56) 0.02 2.02 (1.22–3.32) 0.01 2.64 (1.54–3.95) <0.01 3.26 (1.76–6.06) <0.01
Haematological malignancy 1.24 (0.43–3.58) 0.69 1.51 (0.38–5.97) 0.56 1.62 (0.59–4.47) 0.35 3.63 (0.81–16.32) 0.09
Reference: no comorbid illness
Primary renal diagnosis
Other 2.98 (1.30–6.83) 0.01 1.26 (0.40–3.92) 0.69 4.73 (1.74–12.88) <0.01 1.54 (0.34–6.93) 0.57
Unknown 2.44 (0.99–6.01) 0.05 2.16 (0.69–6.75) 0.18 0.89 (0.26–3.02) 0.86 3.96 (0.87–18.14) 0.08
Vascular 4.53 (1.05–19.64) 0.04 4.01 (0.71–22.52) 0.12 1.34 (0.18–9.74) 0.77 9.91 (0.81–120.77) 0.07
Autoimmune 3.11 (1.23–7.87) 0.02 2.63 (0.84–8.22) 0.10 6.07 (2.13–17.27) <0.01 0.28 (0.04–2.13) 0.22
ADPKD 0.81 (0.20–3.33) 0.77 0.32 (0.04–2.90) 0.31 NAb 1.00 NAb .
Reference: DM . . . .
Ethnicity
Asian 0.69 (0.43–1.12) 0.13 0.89 (0.49–1.61) 0.70 0.52 (0.31–0.89) 0.02 0.40 (0.19–0.84) 0.02
Black 0.89 (0.49–1.62) 0.70 1.30 (0.55–2.60) 0.46 0.62 (0.32–1.24) 0.18 1.16 (0.55–2.45) 0.70
Other 1.06 (0.37–3.05) 0.92 1.65 (0.55–4.96) 0.38 0.30 (0.07–1.36) 0.12 0.23 (0.03–1.89) 0.17
Reference: White . . . .
Gender
Male 1.07 (0.69–1.64) 0.78 0.85 (0.52–1.41) 0.54 1.12 (0.70–1.81) 0.64 1.57 (0.82–3.02) 0.18
Reference: female . .
Adjusted for age, sex, primary renal diagnosis, ethnicity and comorbid illness.
aReference category is planned.
bNo patients with ADPKD in this category.
FIGURE 2: Rate of change of eGFR in the 12 months preceding dialysis initiation.
Data represent mean and standard mean error. Compared with planned start-
ers, unplanned starters with systemic illness (4.56 0.9, P<0.001), unplanned
starters with accelerated unexpected decline in renal function (3.66 1.2,
P¼0.029), urgent starters with systemic illness (266 1.5, P<0.001) and urgent
starters with unexpected accelerated decline in renal function (136 2.4,
P<0.001) had a greater rate of eGFR decline in the 12 months preceding dialysis.
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stratification and identifying modifiable risk factors, is funda-
mental to improving patient care.
On initiation of dialysis, the eGFR of patients starting acute
dialysis was similar to that of planned starters (apart from ur-
gent starters with an unexplained decline to ESKD). The rate of
eGFR decline 12 months prior to dialysis initiation of patients re-
quiring urgent dialysis was greatest. The rapid and often unpre-
dictable loss of renal function in the context of acute systemic
illness may make any intervention to avert acute dialysis start
difficult.
Urgent dialysis initiation
Delayed or late referral remains a negative aspect of renal care
and is well known to be associated with adverse outcomes [22],
including more frequent and longer hospitalization [23], subop-
timal vascular access [24], poorer psychological well-being [25]
and lower uptake of home dialysis therapies [26–28]. The rea-
sons for late referrals need to be ascertained, as it may facilitate
prevention of progression to ESKD. A shorter duration of pre-
dialysis care is associated with increased morbidity and mortal-
ity [1, 4, 5, 7].
In all, 20.7% of our cohort had a late referral and urgent start
on dialysis, consistent with the overall national UK rate of ur-
gent dialysis initiation of 17% [29]. Similarly in the USA and
Australia, 20% of patients requiring chronic RRT are referred
to renal services within 3–4 months [2, 30].
Patients known to renal services for <3 months required
acute dialysis because of acute systemic illness in 62% of cases.
Unsurprisingly, the first presentation of autoimmune GN was a
significant risk factor. This reflects the nature of our nephrology
service, which is a tertiary referral centre for renal vasculitis.
‘Other’ renal diseases were also a significant risk factor and
were comprised primarily of patients requiring nephrectomy
for major surgery and haematological malignancy. This illus-
trates the important distinction between ‘late presentation’ and
‘late referral’. The same is true for patients at the opposite end
of the spectrum, with slowly progressive but asymptomatic re-
nal dysfunction over many years. In our cohort, 7% required di-
alysis within 3 months of presentation, without any obvious
cause of ESKD. These patients often presented with small
scarred kidneys on ultrasound scans and with negative immu-
nology on serological tests.
The UK renal registry reports an overall national ‘late refer-
ral’ rate of 12.2%, with considerable variation in late presenta-
tion rates (5–40%) between UK renal centres [29]. We were able
to ascertain historical serum eGFR values in half the patients
referred to us within 3 months of requiring dialysis (urgent
starters). A significant proportion of these patients had CKD
up to 12 months prior to the initiation of dialysis, yet were
referred within 3 months of requiring dialysis. Deficiencies in
primary and secondary care recognition of CKD and delays in
activating referral pathways for specialist nephrology input
may be contributory. Laboratory eGFR reporting and prompts
(e-alerts) to consider specialist referral are now routinely used
by many centres. A recent UK-wide initiative (Assist-CKD)
provides a graphical surveillance tool to monitor eGFR and
identifies people with CKD who are at greatest risk of disease
progression [31].
Unplanned dialysis initiation
One-third of patients requiring acute dialysis initiation had
been known to renal services for >3 months, 55% of whom had
an association with acute systemic illness. The cardiovascular
disease burden and advancing age associated with acute sys-
temic illness are a reflection of the vulnerability of this ad-
vanced CKD cohort to acute illness precipitating the need for
emergency dialysis.
One-third of patients with unplanned starts presented with
an accelerated unexpected decline in renal function precipitat-
ing the need for emergency dialysis. The cause of the acceler-
ated decline in renal function compared with planned starters
remains unclear. Clinical judgement among nephrology consul-
tants has been shown to be sensitive but not specific in predict-
ing the need for dialysis, and eGFR was the only independent
correlate of predicted time to dialysis [32]. Diabetes is an inde-
pendent risk factor for unplanned dialysis initiation. Diabetic
patients may warrant more frequent eGFR monitoring, particu-
larly those at higher risk of rapid decline, that is, with advanced
albuminuria, ongoing poor glycaemic control, presence of reti-
nopathy and neuropathy and those with dyslipidaemia [33].
A significant proportion of patients (11.5%) known to renal
services for >3 months required acute dialysis associated with
‘health care behaviour–related factors’. This included non-
compliance and patient denial. Although we do not have de-
tailed information on health care education given to individual
patients in this cohort, we routinely facilitate a patient educa-
tion programme preparing patients (typically with eGFR
<20 mL/min) for dialysis. Such programmes have been shown
to improve patient mortality [34, 35]. Yet, for a small proportion
of patients, additional measures may be required to achieve
better patient engagement [36] and improve equity of dialysis
access.
Strengths and limitations
The main limitation of our study is its retrospective nature.
However, a record of all patients initiating dialysis has been pro-
spectively collected to ensure no bias in patient selection. Pre-
emptive renal transplant recipients were excluded from the
analysis, as the primary objective of this analysis was to com-
pare outcomes of patients undergoing elective or emergency di-
alysis initiation. One-year survival among pre-emptive renal
transplant recipients was 99%, compared with 92% among
planned dialysis initiation.
We do not have complete data on eGFR values in the
12 months preceding dialysis initiation, with less than half the
values available for the cohort at some time points among ur-
gent dialysis starters. While we run a comprehensive patient
education programme available for all patients, we do not have
details on the number of clinic attendances and educational
sessions each patient has had.
Estimating the eGFR change by linear regression may poten-
tially mask slow progression with acute chronic decline in the
month prior to dialysis initiation. Despite this, there was a sig-
nificant difference in eGFR change in the 12 months preceding
dialysis between emergency and planned dialysis initiation.
Our findings may not reflect other populations of dialysis
patients, given the ethnic diversity in our patient cohort. The
high proportion of patients with diabetic nephropathy is likely
to reflect the greater proportion of African and Asian patients in
our population. The proportion of patients with hypertensive
nephrosclerosis in our cohort is considerably lower than that
reported in European data [37], although this may reflect the dif-
ficulty in defining patients with true ‘hypertensive nephroscle-
rosis’, as hypertension may be causal, an effect of or an
epiphenomenon to CKD.
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Despite these limitations, our study has a number of
strengths. Compared with other studies with this level of detail,
we describe a large patient cohort. We report differences in risk
factors for initiating emergency dialysis based on the reasons
behind emergency dialysis starts. We also demonstrate infor-
mation about the rate of decline in eGFR in the 12 months pre-
ceding dialysis initiation in the context of reasons for acute
dialysis starts. Future work needs to focus on ensuring timely
referral of CKD patients to renal services.
CONCLUSIONS
Acute initiation of dialysis is common, even in patients known
to renal services. Acute systemic illness and an unexplained de-
cline in renal function are common reasons for requiring acute
RRT initiation. A proportion of patients initiating dialysis were
known to have CKD even 12 months prior to the initiation of
RRT but were only referred to renal services within 3 months of
needing dialysis. Cardiovascular comorbidities and risk factors
and advancing age were significant risk factors for acute dialy-
sis initiation among patients known to renal services for
>3 months. The rapid and often unpredictable loss of renal
function in the context of acute systemic illness may make any
intervention to avert emergency dialysis start difficult. Patients
with a rapid decline in GFR are at greatest risk of progression to
ESKD and merit more frequent GFR monitoring to limit progres-
sion and facilitate earlier dialysis planning.
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